Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950162-03-000916
Filing Date
2003-06-13
Accepted
2003-06-13 17:13:37
Documents
1
Period of Report
2003-06-11

Document Format Files

Seq Description Document Type Size
1 sigmataufinform4061303_ex.html 4  
1 sigmataufinform4061303_ex.xml 4 5647
  Complete submission text file 0000950162-03-000916.txt   8238
Mailing Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 3019611992
REGENERX BIOPHARMACEUTICALS INC (Issuer) CIK: 0000707511 (see all company filings)

EIN.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address VIA SUDAFRICA 20 00144 ROME ITALY
Business Address VIA SUDAFRICA 20 00144 ROME ITALY
SIGMA TAU FINANZIARIA SPA (Reporting) CIK: 0001092601 (see all company filings)

Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-15070 | Film No.: 03744244

Mailing Address RUA DOS FERREIROS,260 FUNCHAL MADEIRA S1 9000-082
Business Address
DEFIANTE FARMACEUTICA LDA (Reporting) CIK: 0001168857 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-15070 | Film No.: 03744245